- Home
- VLGEA vs VALN Comparison
VLGEA vs VALN Comparison
Compare VLGEA & VALN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VLGEA
- VALN
- Stock Information
- Founded
- VLGEA 1937
- VALN 2012
- Country
- VLGEA United States
- VALN France
- Employees
- VLGEA N/A
- VALN N/A
- Industry
- VLGEA Food Chains
- VALN Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- VLGEA Consumer Staples
- VALN Health Care
- Exchange
- VLGEA Nasdaq
- VALN Nasdaq
- Market Cap
- VLGEA 541.1M
- VALN 542.5M
- IPO Year
- VLGEA N/A
- VALN 2021
- Fundamental
- Price
- VLGEA $36.38
- VALN $6.00
- Analyst Decision
- VLGEA
- VALN Strong Buy
- Analyst Count
- VLGEA 0
- VALN 3
- Target Price
- VLGEA N/A
- VALN $15.33
- AVG Volume (30 Days)
- VLGEA 94.1K
- VALN 14.6K
- Earning Date
- VLGEA 06-03-2025
- VALN 08-12-2025
- Dividend Yield
- VLGEA 2.75%
- VALN N/A
- EPS Growth
- VLGEA 12.55
- VALN N/A
- EPS
- VLGEA 3.80
- VALN N/A
- Revenue
- VLGEA $2,299,253,000.00
- VALN $201,099,222.00
- Revenue This Year
- VLGEA N/A
- VALN $18.74
- Revenue Next Year
- VLGEA N/A
- VALN $29.26
- P/E Ratio
- VLGEA $9.67
- VALN N/A
- Revenue Growth
- VLGEA 3.94
- VALN 21.64
- 52 Week Low
- VLGEA $26.11
- VALN $3.62
- 52 Week High
- VLGEA $40.15
- VALN $8.66
- Technical
- Relative Strength Index (RSI)
- VLGEA 37.57
- VALN 52.41
- Support Level
- VLGEA $36.53
- VALN $5.57
- Resistance Level
- VLGEA $39.65
- VALN $6.19
- Average True Range (ATR)
- VLGEA 0.93
- VALN 0.29
- MACD
- VLGEA -0.29
- VALN 0.05
- Stochastic Oscillator
- VLGEA 0.60
- VALN 65.60
About VLGEA Village Super Market Inc.
Village Super Market Inc operates a chain of ShopRite supermarkets, a few of which are in northern New Jersey, southern New Jersey, Maryland, and in northeastern Pennsylvania. The company is a member of Wakefern Food Corporation (Wakefern), a retailer-owned food cooperative and owner of the ShopRite name. It consists of one operating segment, the retail sale of food and nonfood products.
About VALN Valneva SE
Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates majority of its revenue from product sales.